U.S. Government

Jousting with the Lancet: More Data, More Debate over Iraqi Deaths

U.S. soldier carries a wounded Iraqi child (Marine Corps photo)It's one of the most controversial questions today: How many Iraqis have died since the 2003 U.S.-led invasion?

That there is no definitive answer should not come as a surprise, given the chaotic situation in Iraq. Still, it's an important question to ask, for obvious humanitarian, moral and political reasons.

Theoretically, the public health surveys and polls that have been conducted in Iraq -- at great risk to the people involved -- should help inform and further the debate. But the data is complicated by different research approaches and their attendant caveats. The matter has been further confused by anemic reporting, with news articles usually framed as a "he said / she said" story, instead of an exploration and interpretation of research findings.

These are the conditions under which spin thrives: complex issues, political interests and weak reporting. So it's not too surprising that last month saw a spate of what international health researcher Dr. Richard Garfield calls "Swift Boat editorials."

Great Lakes Study Suppressed

Suppressed Centers for Disease Control study"For more than seven months, the nation's top public health agency has blocked the publication of an exhaustive federal study of environmental hazards in the eight Great Lakes states, reportedly because it contains such potentially 'alarming information' as evidence of elevated infant mortality and cancer rates," reports Sheila Kaplan.

No

Beyond Advertising: The Pharmaceutical Industry's Hidden Marketing Tactics

In early January, the U.S. House Committee on Energy and Commerce began investigating celebrity endorsements in television ads for brand-name drugs. The investigation was sparked by Pfizer's commercials for its best-selling cholesterol drug Lipitor. These direct-to-consumer (DTC) ads feature Dr. Robert Jarvik, a pioneer in the development of the artificial heart. Viewers are not told that Jarvik is not a cardiologist, nor is he licensed to practice medicine. His presentation as a trusted expert, Pfizer presumably hopes, is enough to persuade viewers to ask their doctors for Lipitor by name. And that would help erode the increasing competition from generic alternatives.

A Comical Attempt to Win Young Hearts and Minds

Want to earn up to $2.4 million to produce and distribute across Iraq 12 issues of a comic book designed to "highlight the professionalism of the Iraqi Special Operations Forces (ISOF) and to enhance the public perception of the Iraqi Security Forces (ISF) as a capable, well-trained, and professional fighting force"? Well, you'll have to compete with the Lincoln Group, the PR firm that previously placed U.S.

No

Barn Raising Day for Superdelegate Transparency

Citizen journalism logoSince the Superdelegate Transparency Project launched on Congresspedia last week, dozens of people have helped flesh out the facts about the so-called "superdelegates" whose votes may determine whether Hillary Clinton or

Yes

Without Academic Partnerships, the Tobacco Industry Loses Power

Taking research grants helps tobacco companies thriveA February 9 Los Angeles Times article about University of California, Los Angeles professor Edythe London taking a $6 million grant from Philip Morris to study the brains of child smokers and monkeys addicted to nicotine once again raises questions about the appropriateness of university researchers accepting tobacco industry funding. Philip Morris denied that they have a stake in this particular project, but the denial had little credibility since the company no doubt will benefit from understanding more about youth smoking and nicotine addiction. After all, the future of their business depends on these two topics. Still, we wonder why any person curious enough to be engaged in scientific research isn't also curious enough to find out what's in it for Philip Morris before they accept the funds? These days, the answer is as close as your computer.

Pages

Subscribe to U.S. Government